Exosomes from Human Urine-Derived Stem Cells Promote Neurogenesis Via Histone Deacetylase6 Regulation in Ischemic Stroke

Xiaozheng Ling,Guowei Zhang,Qingwei Zhu,Juntao Zhang,Qing Li,Xin Niu,Guowen Hu,Yunlong Yang,Yang Wang,Zhifeng Deng

DOI: https://doi.org/10.2139/ssrn.3288885

2018-01-01

Abstract:Background: Human urine-derived stem cells (USCs) are receiving much more attention in tissue regeneration and injury repair. Exosomes derived from USCs (USCs-Exo) have recently been suggested to mediate the restorative effects of USCs. However, whether USCs-Exo play a protective role in stroke remains unknown. Methods: Therapeutic effect of USCs-Exo in vivo was evaluated by cerebral infarction and neurological behavior. The proliferation and differentiation of neural stem cells (NSCs) was determined by double immunofluorescent staining. The viability, apoptosis, proliferation, and differentiation of NSCs subjected to oxygen glucose deprivation/reoxygenation (OGD/R) were assessed, respectively. The protein expression and activity of HDAC6, and the expression levels of miRNAs both in vivo and in vitro were assessed to detect the possible mechanism. Findings: We found that intravenous injection of USCs-Exo reduced brain infarct volume and improved functional recovery by enhancing the proliferation and differentiation of NSCs in ischemic rats. The in vitro results suggested that USCs-Exo increase viability, reduce apoptosis, and promote the proliferation and neuronal differentiation of NSCs after OGD/R. We further found that miR-206 contained in USCs-Exo is associated with the therapeutic efficacy for neurogenesis through the inhibition of histone deacetylase6 (HDAC6). Interpretation: Our study demonstrates that USCs-Exo can improve neurological function recovery by promoting neurogenesis, which is attributed to miR-206-mediated HDAC6 inhibition. Our research suggests that the use of USCs-Exo represents a novel therapeutic strategy for stroke recovery. Funding Statement: This work was funded by National Natural Science Foundation of China (Nos. 81671209, 81471243, and 81472152). Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: Written informed consent was obtained from all of the volunteers, and all of the experimental procedures were approved by the Ethics Committee of the Shanghai Sixth People’s Hospital affiliated with Shanghai Jiaotong University.